• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, September 13, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Corning to showcase latest in pharmaceutical glass technologies at CPhI Worldwide

Bioengineer by Bioengineer
October 23, 2017
in Biology
Reading Time: 4 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

CORNING, N.Y. — Corning Incorporated (NYSE: GLW) announced it will exhibit Corning Valor™ Glass at CPhI Worldwide in Frankfurt, Germany, Oct. 24 – 26.

Valor Glass was announced in late July, in collaboration with Merck (NYSE:MRK) and Pfizer (NYSE: PFE), as a remarkable new glass technology. Valor Glass mitigates several longstanding issues with the performance of current pharmaceutical glass packaging and will be displayed in the InnoPack Zone, Stand No. 42G32.

Valor Glass offers benefits to both pharmaceutical manufacturers and to patients receiving injections because it:

  • Offers superior chemical durability with low extractable concentrations, making Valor Glass containers ideally suited to eliminate delamination and protect drug products. Glass delamination can cause adverse patient events and lead to costly corporate recalls for drug manufacturers
  • Resists damage and breakage during pharmaceutical processing and transit, as well as during in-home and clinical settings
  • Prevents cracks that may lead to contamination, loss of sterility, or product recalls
  • Substantially reduces particulate generation during bulk filling operations, thereby reducing the risk of particle contamination
  • Enables smoother filling operations with fewer glass-related interventions

"We are excited to showcase Valor Glass for the first time at an industry event. The response from the industry and our customers since we announced Valor Glass in July has been exceptional," said Ron Verkleeren, general manager and vice president of Corning Pharmaceutical Technologies. "We are leveraging our expertise in glass science, optical physics, vapor deposition, precision forming, and extrusion to deliver a 21st-century glass to protect medicines."

Pharmaceutical and biologic manufacturers are encouraged to visit the Corning booth to learn more about Corning Pharmaceutical Technologies' portfolio. Corning representatives will be available to discuss more about Valor Glass' benefits and will conduct live Valor Glass demonstrations in the booth.

###

Forward-Looking and Cautionary Statements

This press release contains "forward-looking statements" (within the meaning of the Private Securities Litigation Reform Act of 1995), which are based on current expectations and assumptions about Corning's financial results and business operations, that involve substantial risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include: the effect of global political, economic and business conditions; conditions in the financial and credit markets; currency fluctuations; tax rates; product demand and industry capacity; competition; reliance on a concentrated customer base; manufacturing efficiencies; cost reductions; availability of critical components and materials; new product commercialization; pricing fluctuations and changes in the mix of sales between premium and non-premium products; new plant start-up or restructuring costs; possible disruption in commercial activities due to terrorist activity, armed conflict, political or financial instability, natural disasters, adverse weather conditions, or major health concerns; adequacy of insurance; equity company activities; acquisition and divestiture activities; the level of excess or obsolete inventory; the rate of technology change; the ability to enforce patents; product and components performance issues; retention of key personnel; stock price fluctuations; and adverse litigation or regulatory developments. These and other risk factors are detailed in Corning's filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the day that they are made, and Corning undertakes no obligation to update them in light of new information or future events.

Digital Media Disclosure

In accordance with guidance provided by the SEC regarding the use of company websites and social media channels to disclose material information, Corning Incorporated ("Corning") wishes to notify investors, media, and other interested parties that it intends to use its website (http://www.corning.com/worldwide/en/about-us/news-events.html) to publish important information about the company, including information that may be deemed material to investors. The list of websites and social media channels that the company uses may be updated on Corning's media and website from time to time. Corning encourages investors, media, and other interested parties to review the information Corning may publish through its website and social media channels as described above, in addition to the company's SEC filings, press releases, conference calls, and webcasts.

About Corning Incorporated

Corning (www.corning.com) is one of the world's leading innovators in materials science, with a 166-year track record of life-changing inventions. Corning applies its unparalleled expertise in glass science, ceramics science, and optical physics along with its deep manufacturing and engineering capabilities to develop category-defining products that transform industries and enhance people's lives. Corning succeeds through sustained investment in RD&E, a unique combination of material and process innovation, and deep, trust-based relationships with customers who are global leaders in their industries.

Corning's capabilities are versatile and synergistic, which allows the company to evolve to meet changing market needs, while also helping our customers capture new opportunities in dynamic industries. Today, Corning's markets include optical communications, mobile consumer electronics, display technology, automotive, and life sciences vessels. Corning's industry-leading products include damage-resistant cover glass for mobile devices; precision glass for advanced displays; optical fiber, wireless technologies, and connectivity solutions for state-of-the-art communications networks; trusted products to accelerate drug discovery and delivery; and clean-air technologies for cars and trucks.

Media Relations Contacts:

Lee Bansil
(607) 974-7341
[email protected]

Chelsea Tracy-Zelko
(607) 974-4450
[email protected]

Investor Relations Contact:

Ann H.S. Nicholson
(607) 974-6716
[email protected]

Follow Corning: RSS Feeds | Facebook | Twitter | YouTube

Media Contact

Lee Bansil
[email protected]
607-974-7341

Share12Tweet8Share2ShareShareShare2

Related Posts

Evaluating Rohu Fry Transport: Key Water Quality Insights

September 13, 2025
blank

Unveiling Arabidopsis Aminotransferases’ Multi-Substrate Specificity

September 13, 2025

Evaluating Energy Digestibility in Quail Feed Ingredients

September 12, 2025

Gene Body Methylation Drives Diversity in Arabidopsis

September 12, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    152 shares
    Share 61 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    65 shares
    Share 26 Tweet 16
  • A Laser-Free Alternative to LASIK: Exploring New Vision Correction Methods

    49 shares
    Share 20 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Non-Coding RNAs Crucial in Topotecan Cancer Response

Delayed Diagnosis Offers No Harm to Intussusception Success

Evaluating Rohu Fry Transport: Key Water Quality Insights

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.